2025-07-29 - Analysis Report
Okay, here's the analysis of TG Therapeutics Inc (TGTX) based on the provided data, presented in a report format.

## TGTX Stock Analysis Report

**Ticker:** TGTX
**Company Name:** TG Therapeutics Inc.
**Company Overview:** TG Therapeutics is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance Relative to S&P 500 (VOO)

*   **TGTX Cumulative Return:** 61.78%
*   **VOO Cumulative Return:** 99.63%
*   **Absolute Deviation (TGTX - VOO):** -36.3%
*   **Deviation Range:** Max: 401.1, Min: -110.5
*   **Relative Deviation:** 14.5 (Indicates TGTX is positioned at the 14.5th percentile of its historical deviation range compared to VOO).

**Analysis:** TGTX has underperformed the S&P 500 (VOO) over the analyzed period. The relative deviation suggests that this underperformance is closer to the lower end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR      | MDD   | Alpha   | Beta   | Cap(B) |
| ---------- | --------- | ----- | ------- | ------ | ------ |
| 2015-2017  | -6.0%     | 56.5% | -35.0%  | -0.1   | 1.3    |
| 2016-2018  | -8.0%     | 58.6% | -26.0%  | 0.0    | 0.7    |
| 2017-2019  | 74.0%     | 58.6% | 44.0%   | 0.0    | 1.8    |
| 2018-2020  | 402.0%    | 58.6% | 382.0%  | -0.4   | 8.3    |
| 2019-2021  | 125.0%    | 63.5% | 76.0%   | -0.5   | 3.0    |
| 2020-2022  | -76.0%    | 70.4% | -78.0%  | -0.6   | 1.9    |
| 2021-2023  | -350.0%   | 70.4% | -368.0% | -0.8   | 2.7    |
| 2022-2024  | 71.0%     | 73.1% | 45.0%   | -0.9   | 4.8    |
| 2023-2025  | 69.0%     | 73.1% | 17.0%   | 0.4    | 5.7    |

**Analysis:**
*   **CAGR:** Wide fluctuations in Compound Annual Growth Rate (CAGR) indicate high volatility.
*   **MDD:** Maximum Drawdown (MDD) is substantial, suggesting significant potential losses.
*   **Alpha:**  Alpha is frequently negative, meaning underperformance relative to the benchmark (risk-adjusted).
*   **Beta:** Beta fluctuates, indicating varying degrees of correlation with the market.

### 2. Recent Price Action

*   **Current Price:** \$35.99
*   **Previous Close:** \$36.90
*   **Change:** -2.47%
*   **5-Day Moving Average:** \$36.878
*   **20-Day Moving Average:** \$37.1802
*   **60-Day Moving Average:** \$36.6467

**Analysis:** The stock price is currently below all three moving averages (5, 20, and 60 days), suggesting a potential short-term downward trend. The recent price change of -2.47% indicates some selling pressure.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3286 (Low Risk)
*   **RSI:** 51.64 (Neutral)
*   **PPO:** -0.5094 (Bearish)
*   **Hybrid Signal:** Cash_60%_Sell - Caution advised.
*   **20-Day Relative Deviation Change:** -1.5 (Negative change suggests a short-term decline).
*   **Expected Return (%):** -275.6% (Significant underperformance relative to S&P 500 over the long term).

**Analysis:**
*   The low MRI suggests a relatively stable market environment.
*   The RSI is neutral, indicating neither overbought nor oversold conditions.
*   The negative PPO suggests a bearish trend, meaning the short-term moving average is below the long-term moving average.
*   The Hybrid Signal is a strong sell signal, suggesting caution and a possible reduction in holdings.
*   The significantly negative expected return indicates potential long-term underperformance.
*   The recent price change of -2.47% suggests a potential quick reaction or increased volatility in the short term, which needs to be considered alongside the other technical indicators.

### 4. Recent News & Significant Events

*   **[2025-07-27]:**  Major business developments, regulatory changes, or market events.
*   **[2025-07-25]:** Analyst discussions of recent performance and outlook.
*   **[2025-07-26]:** Notable stock volatility.
*   **[2025-07-28]:**  Expert advice to monitor recent news and company announcements.

**Analysis:** The news highlights potential catalysts for price movement. The combination of volatility and analyst discussion indicates the stock is under scrutiny and sensitive to news flow. Investors should monitor company announcements and industry developments closely.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출      |
| ------------ | ----- | --------- |
| 2025-05-09   | 0.03  | 0.12 B\$  |
| 2024-11-07   | 0.03  | 0.08 B\$  |
| 2024-08-09   | 0.05  | 0.07 B\$  |
| 2024-05-06   | -0.07 | 0.06 B\$  |
| 2025-05-09 | -0.07 | 0.06 B$ |

**Analysis:** The recent EPS trend has been volatile, but positive for the latest two quarters. Revenues have generally increased over the last few quarters. This suggests improving financial performance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| ------------ | ------- | ------------- |
| 2025-03-31   | \$0.12B | 87.14%        |
| 2024-12-31   | \$0.11B | 85.77%        |
| 2024-09-30   | \$0.08B | 88.86%        |
| 2024-06-30   | \$0.07B | 88.70%        |
| 2024-03-31   | \$0.06B | 91.43%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE      |
| ------------ | ------- | -------- |
| 2025-03-31   | \$0.24B | 2.13%    |
| 2024-12-31   | \$0.22B | 10.49%   |
| 2024-09-30   | \$0.19B | 2.02%    |
| 2024-06-30   | \$0.18B | 3.87%    |
| 2024-03-31   | \$0.16B | -6.69%   |

**Analysis:**

*   **Revenue:** Revenue has generally been increasing, indicating growth.
*   **Profit Margin:** Consistently high profit margins suggest efficient operations.
*   **Equity:** Increasing equity suggests a strengthening balance sheet.
*   **ROE:** Return on Equity (ROE) is variable, but has improved significantly in recent quarters.

### 7. 종합 Analysis & Recommendations

**Summary:**

TGTX has underperformed the S\&P 500, exhibiting high volatility and significant potential for losses. While recent earnings and financial data show improving revenue, profit margins, and equity, the technical indicators, particularly the negative PPO, "Cash_60%_Sell" Hybrid signal, and negative expected return, suggest caution. Recent news indicates the stock is sensitive to market events and analyst scrutiny. The low MRI suggests a relatively stable market environment, but the strong negative expected return and the Hybrid sell signal should be given considerable weight.

**Recommendation:**

Given the mixed signals, a cautious approach is warranted.

*   **Risk-Averse Investors:** Consider reducing or exiting positions in TGTX, given the negative expected return and strong sell signal.
*   **Aggressive Investors:** If confident in the company's long-term prospects, monitor news and financial announcements closely. Consider implementing risk management strategies like stop-loss orders.

**Disclaimer:** This analysis is based on the provided data and should not be considered financial advice. Investors should conduct their own due diligence before making investment decisions.
